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In Brief
During the course of a viral infection,
CD4+ and CD8+ T lymphocyte activation
is initially separated spatially, but a
subset of dendritic cells acts as a
platform to orchestrate their
communication to optimize CD8+ T cell
expansion and memory function.
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Host defense against viruses and intracellular para-
sites depends on effector CD8+ T cells, whose
optimal clonal expansion, differentiation, and mem-
ory properties require signals from CD4+ T cells.
Here, we addressed the role of dendritic cell (DC)
subsets in initial activation of the two T cell types
and their co-operation. Surprisingly, initial priming
of CD4+ and CD8+ T cells was spatially segregated
within the lymph node and occurred on different
DCs with temporally distinct patterns of antigen pre-
sentation via MHCI versus MHCII molecules. DCs
that co-present antigen via both MHC molecules
were detected at a later stage; these XCR1+ DCs
are the critical platform involved in CD4+ T cell
augmentation of CD8+ T cell responses. These find-
ings delineate the complex choreography of cellular
interactions underlying effective cell-mediated anti-
viral responses, with implications for basic DC sub-
set biology, as well as for translational application
to the development of vaccines that evoke optimal
T cell immunity.
INTRODUCTION
The induction of an adaptive immune response requires the
interaction of several lymphoid and myeloid cell types. For the
generation of cytotoxic T lymphocytes (CTL), initial activation
of naive CD8+ T cells occurs via antigen-presenting cells (APC)
that engage the antigen-specific T cell receptor (TCR) and other
stimulatory surface receptors of these lymphocytes (Curtsinger
and Mescher, 2010). The critical MHCI molecules involved in
TCR recognition by CD8+ T cells can be loaded with antigenic1322 Cell 162, 1322–1337, September 10, 2015 ª2015 Elsevier Inc.determinants by a direct antigen-presentation pathway involving
cytosolic proteins or by a cross-presentation pathway, which is
fueled by extracellular proteins (Kurts et al., 2010). The latter is
believed to play an essential role for pathogens that do not
directly infect professional APC.
A second conventional T cell, the CD4+ helper T cell, is acti-
vated via antigen-presenting MHCII molecules. In distinction to
the ligands involved in activation of CD8+ T cells, antigenic pep-
tides presented by MHCII molecules are typically derived from
extracellular proteins or intracellular proteins that are recycled
from the cell surface (Germain, 1994). These CD4+ T cells
provide crucial soluble and membrane-associated signals to
antigen-specific B lymphocytes, leading to effective adaptive
humoral immunity (Crotty, 2014). As with B cells and humoral re-
sponses, CD4+ T cells also provide molecular ‘‘help’’ to CTL,
optimizing cellular immune responses by enhancing CD8+
T cell clonal expansion, differentiation, and survival (Castellino
and Germain, 2006).
Although the functional parallel is clear, a conceptual problem
in comparing CD4+ T cell help for humoral versus cellular re-
sponses in mouse models is that the interaction between CD4+
and CD8+ T cells cannot be direct, based on TCR engagement,
asmouse CD8+ T cells do not express the necessary MHCII mol-
ecules to provide ligands for the CD4+ T cell TCR. This paradox
was resolved by experiments showing that dendritic cells (DCs)
serve as a platform to mediate communication between CD4+
and CD8+ T cells (Mitchison and O’Malley, 1987; Ridge et al.,
1998). Both T cell subsets must interact with the same DC in
an antigen- and TCR-dependent manner, meaning that the
‘‘platform’’ DC must present antigen to CD4+ and CD8+ T cells
via both the MHCII and MHCI pathways, respectively (Bennett
et al., 1997; Cassell and Forman, 1988).
Given that naive lymphocytes specific for a given foreign
antigen are rare, it has been argued that the likelihood of a
(simultaneous, random) three-cell encounter is too low to be
effective at driving the responses in question (Bevan, 2004).
This argument has been weakened by experiments showing
that (1) a DC that had interacted with a CD4+ T cell could help
a CD8+ T cell even after the CD4+ T cell was removed, removing
the need for contemporaneous three-cell clustering (Ridge et al.,
1998) and (2) DC-CD4+ T cell interactions lead to the production
of the chemokines CCL3/4 that attract CD8+ T cells via CCR5 to
the licensed DC optimizing rare cell contacts (Castellino et al.,
2006).
The same intravital imaging methods that revealed such che-
mokine-mediated guidance also showed that, upon encounter
with antigen-laden DCs, T cells arrest and initiate long-term in-
teractions lasting for several hours (16–20 hr) (Bousso and
Robey, 2003; Miller et al., 2002; Stoll et al., 2002). This means
that both CD4+ and CD8+ T cells would be substantially delayed
in finding a commonDC evenwith chemokine guidance. Further-
more, the past decade has seen an increasingly detailed parsing
of dendritic cells into distinct subsets with specific localizations
within secondary lymphoid tissues (Gerner et al., 2012; Kissenp-
fennig et al., 2005), as well as the emergence of strong evidence
for preferential presentation of antigen via MHCI and MHCII by
different DC types (den Haan et al., 2000; Dudziak et al., 2007;
Schnorrer et al., 2006). Together, the dynamic considerations
and the complexity of DC biology raise the crucial issue of
when, where, and on which DC do CD4+ and CD8+ T cells
become activated and communicate.
In light of these unresolved questions, the present study aimed
to elucidate the spatial and temporal events that occur during
CD4+ T cell augmentation of CD8+ T cells responses (‘‘help’’)
and to reveal the location and identity of the DC subset(s) that
serve(s) as the communication platform for CD4+ and CD8+
T cells. Surprisingly, we found that early post-infection, anti-
gen-specific activation of CD4+ and CD8+ T cells is spatially
separated and mediated via non-infected and infected DC,
respectively. XCR1+ (CD8a+) DCs, which have been described
to play a central role in CD8+ T cell priming, appeared to be
dispensable for this initial activation of CD8+ T cells. After the
triggering of both T cell subsets, CD4+ and CD8+ T cells translo-
cated to a specific area in the paracortex, where they interacted
with a third, non-infected XCR1+ DCs population, defining the
platform for delivery of help. These findings delineate the com-
plex choreography of cellular interactions underlying effective
cell-mediated anti-viral responses with parallels to the spatio-
temporal events involved in delivery of CD4+ T cell help during
humoral immune responses.
RESULTS
Direct Priming of CD8+ T Cells Does Not Require
XCR1+ DC
To understand how CD8+ T cells and CD4+ T cells interact with
DCs during the induction of robust cell-mediated immune re-
sponses, we used a model system of vaccinia virus (VV) infec-
tion that supports both direct and cross-presentation pathways
and elicits a CD4+ help-dependent CD8+ T cell response (Nor-
bury et al., 2001; Wiesel et al., 2010). To allow for a time-
resolved analysis of the cellular events, we initially carried out
our experiments with the replication-deficient variant MVA
(modified vaccinia virus Ankara). This attenuated virus producesCa single round of infection with full expression of early and late
viral antigens (Drexler et al., 2004). 4 hr after intravenous (i.v.)
infection of mice with MVA-GFP, we could detect infected
DCs based on GFP expression. Phenotypic analysis of infected
DCs revealed a comparable infection rate among CD8a+ and
CD11b+ DCs in the spleen (Figure 1A). After infection with a re-
combinant virus that also expresses the ovalbumin-derived
SIINFEKL determinant (MVA-NP-S-GFP), the infected DCs
also presented virally expressed antigens via MHCI as quanti-
fied by antibody staining with clone 25.D1, which recognizes
SIINFEKL bound to the mouse MHCI molecule H-2Kb. To test
whether such directly infected DC could drive CD8+ T cell
proliferation, we infected Kbm1 animals (Kbm1 is a mutant Kb
unable to bind SIINFEKL) with MVA-OVA and MVA-OVA-Kb,
respectively. In this experimental set-up, only MVA-OVA-Kb-in-
fected DCs were able to present antigen and promote prolifera-
tion of OT-I cells (CD8+ ovalbumin-specific, TCR transgenic
T cells), whereas non-infected or MVA-OVA-infected DC were
unable to stimulate OT-I cell proliferation in culture (Figure 1B).
This demonstrates that directly infected DCs present viral anti-
gens and induce proliferation of antigen-specific CD8+ T cells
ex vivo. In vivo, we could detect direct interactions between
MVA-OVA-GFP-infected DCs and transferred OT-I lymphocytes
shortly after infection using intravital two-photon microscopy
(IVM) and analysis of stained lymph node (LN) sections (Movie
S1 and Figure 1C). Arrested T cells were typically seen at the
subcapsular sinus (SCS) and formed clusters in the interfollicular
area and the cortical ridge as previously reported (Hickman
et al., 2008; Kastenmu¨ller et al., 2013). Because both DC and
macrophages populate the area in which we see clusters of
OT-I cells early after infection, we depleted macrophages using
clodronate liposomes or used additional DC-specific reporter
animals (Figures S1A–S1C) and analyzed clusters shortly after
MVA-OVA-GFP infection. These data also indicated that DCs
are the predominant cellular targets of early antigen recognition
by the OT-I cells.
To elucidate whether different infected DC subsets have a dif-
ferential capacity to stimulate OT-I cells, we infected mice i.v.,
sorted splenic CD11b+ or CD8a+ DCs 8 hr later, and co-cultured
the sorted cells with CFSE-labeled OT-I cells. At 72 hr post-co-
culture, we consistently observed similar proliferation of OT-I
cells after co-incubation with either DC subset (Figures 1D and
S1D). CD8a+ DCs substantially overlap with the XCR1+ DC
subpopulation (Becker et al., 2014). Therefore, to further test
whether CD8a+ DCs are required for activation of OT-I cells
in vivo, we transferred OT-I cells into wild-type (WT) or XCR1-
DTR animals (Yamazaki et al., 2013), treated them with Diph-
theria toxin (DTX) to deplete the XCR1+DCs, infected the animals
with MVA-OVA in the footpad (f.p.), and then analyzed the
expression of the early activation markers CD69 and CD25 on
OT-I cells in the draining lymph node (dLN) 12 hr later. We found
that the early activation of OT-I cells was unaltered in the
absence of XCR1+ DCs (Figures 1E and 1F). In contrast, we
found a small but consistent reduction in the early activation of
OT-II cells (CD4+) also specific for OVA but presented by MHCII
molecules (Figures 1E and 1F). In summary, we conclude that
MVA infects various DC subsets in vivo that express and pre-
sent antigens to CD8+ T cells leading to activation and T cellell 162, 1322–1337, September 10, 2015 ª2015 Elsevier Inc. 1323
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Figure 1. Direct Priming of CD8+ T Cells
Does Not Require XCR1+ DCs
(A) Analysis of splenic DC after i.v. infection with
MVA-GFP or MVA-NP-SIINFEKL-GFP (8 hr p.i.).
(B) Analysis of OT-I proliferation after ex vivo co-
incubation with isolated splenic DC from Kbm1
mice infected with MVA-OVA or MVA-OVA-Kb
(8 hr p.i.).
(C) Immunofluorescent (IF) images of a dLN
showing clustering/interaction between trans-
ferred OT-I cells and infected (GFP-expressing)
DC (MVA-OVA-GFP; f.p.; 8 hr p.i.).
(D) Analysis of OT-I proliferation after coincubation
with DC subsets sorted ex vivo (MVA-OVA; i.v.;
8 hr p.i.).
(E and F) Activation marker (CD25/CD69) upregu-
lation on transferred OT-I and OT-II cells in the
popliteal LN 12 hr after f.p. infection (MVA-OVA).
Representative plots (E) and analysis (F) are shown
comparing DTX-treated WT and XCR1-DTR
animals.
Data are representative of three (n = 3) (A–D) and
two (n = 4) (E and F) independent experiments.
(E) Red bars indicate mean values. (C) Scale bars,
100/50 mm. See also Figure S1 and Movie S1.proliferation. For this initial activation, XCR1+(CD8a+)-express-
ing DCs appear to be dispensable.
Early Activation of CD4+ and CD8+ T Cells Occurs on
Spatially Distinct DCs
Having established that antigen-specific CD8+ T cells are initially
activated by infected DCs, we wished to clarify whether CD4+
T cells can provide cognate help via such infected, CD8+
T cell-engaged DCs. To this end, we transferred OT-I and OT-II
cells into mice, infected the animals with MVA-OVA, and1324 Cell 162, 1322–1337, September 10, 2015 ª2015 Elsevier Inc.observed the migratory behavior of the
transferred T cells in situ using IVM.
As expected, we could readily detect
arrested OT-I cells clustering around in-
fected DCs. Surprisingly, however, OT-II
cells did not co-arrest with their CD8+
T cell counterparts (Movie S2 and Fig-
ure 2A). Instead, they migrated similarly
to polyclonal CD4+ control T cells at
around 10 mm/min (Figure 2B). Later after
infection (8–12 hr), we were unable to
detect OT-I/OT-II co-clusters using IVM
(data not shown), although kinetic exper-
iments with isolated cells recovered from
these animals revealed that the majority
of the OT-II cells were activated (CD69hi)
(Figure 2C) and therefore were likely
to have engaged antigen-rich APC by
this time point. These findings suggested
that OT-II cells might be activated in
deeper areas of the LN that are not typi-
cally visualized using IVM. Therefore, we
analyzed frozen LN sections to identifythe location OT-I and OT-II cell co-clusters. In line with our IVM
data, we found that OT-II cells did not accumulate and cluster
in the SCS area in contrast to OT-I cells (Figure 2D), which
were found in proximity to MVA-infected (GFP-expressing) cells.
OT-II cells did not cocluster substantially with OT-I, showing only
random colocalization with OT-I at frequencies similar to OVA
antigen-unspecific polyclonal CD4+ T cells (Figures S2A and
S2B). To further assess this spatial separation of CD4+ and
CD8+ T cells during initial antigen-dependent priming after viral
infection, we analyzed spleen sections at similar time points.
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Figure 2. Priming of CD4+ and CD8+ T Cells Occurs on Spatially Distinct DCs
(A) Images from IVM of the popliteal LN 3–4 hr after MVA-OVA f.p. infection. OT-I, OT-II, and control cells (polyclonal CD4+ T cells) were transferred 24 hr prior to
infection. White arrows indicate brief interaction between clustered OT-I and OT-II or control cells (see also Movie S2).
(legend continued on next page)
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Again, we found a segregation of antigen-specific CD4+ and
CD8+ T cells. OT-I cells were localized at the marginal zone in
proximity to infected APC (Figures S2C and S2D). In contrast,
OT-II cells remained in the white pulp, where they clustered
andwere activated by non-infected (GFP-negative) APC (Figures
S2C and S2D).
To determine whether the segregation of OT-I and OT-II cells
during activation is a phenomenon related to their particular
TCRs, we generated MVA-GP-Venus and analyzed a different
TCR transgenic T cell pair specific for the lymphocytic choriome-
ningitis virus (LCMV) glycoprotein (GP) (Smarta/CD4+, P14/
CD8+). Similar to our previous results, we found accumulation
of antigen-specific CD8+ T cells (P14) around MVA-GP-Venus-
infected DC while antigen-specific CD4+ T cells (Smarta) accu-
mulated in the paracortex (Figures 2E and S2E). Smarta cells
formed homogenous clusters in the paracortex of dLN that
were only randomly intermixed with P14 cells, similar to non-
specific control cells (Figures 2F and 2G). To further evaluate
whether the observed separated activation of antigen-specific
CD4+ versus CD8+ T cells is a more general feature of initial acti-
vation, we examined two additional experimental systems. As a
first approach, we used recombinant adenovirus infections and
found that OT-I cells translocated to the SCS and IFA to interact
with directly infected APC, whereas OT-II cells remained in the
paracortex where they were activated in an antigen-specific
manner (Figures S2F–S2I). Second, we immunized mice with
soluble OVA protein and LPS as adjuvant. Again, we found that
activation of OT-I and OT-II cells is predominantly separated
(Figures S2J–S2M and Movie S3). In summary, we conclude
that the initial activation of antigen-specific CD4+ and CD8+
T cells is segregated and involves distinct DC in different loca-
tions within the lymph node or spleen.
Identification of DCs that Present Viral Antigen via both
MHCI and MHCII Later after Infection
These findings were surprising in light of previous reports
demonstrating that CD4+ help for CD8+ T cells occurs on a single
DC co-presenting MHCI and MHCII antigens (Bennett et al.,
1997; Cassell and Forman, 1988) and our prior studies showing
how chemokines guide T cells to DCs co-presenting MHCI and
MHCII ligands (Castellino et al., 2006). One way to reconcile
the present observations with these prior findings is to postulate
that the licensing and/or the delivery of help occurs later during
the course of infection. To examine this possibility, we trans-
ferred OT-I, OT-II, and polyclonal CD4+ T cells into mice that
had been infected for 30 hr and analyzed the location of these
transferred cells in LN sections 8 hr after transfer (Figure 3A).
With this experimental setup, we could readily detect OT-I and
OT-II cell co-clusters, while polyclonal CD4+ T cells showed(B) Analysis of the mean velocity of transferred T cells using the data shown in M
(C) Analysis of CD69 upregulation on transferred OT-I and OT-II cells in the dLN
(D–F) IF images of a dLN showing the localization of (D) transferred OT-I and OT-I
and (F) transferred P14, Smarta, and polyclonal CD4+ T cells (MVA-GP) 10 hr p.i
(G) Quantification of cluster abundance from four experiments as in (F).
Data are representative of at least two independent experiments (A and B, n = 10
mean values. ***p% 0.001; ns, non-significant. Scale bars (D–F), 100 mm.
See also Figure S2 and Movie S2.
1326 Cell 162, 1322–1337, September 10, 2015 ª2015 Elsevier Inc.an unbiased distribution (Figure 3B). When systematically com-
paring cellular positioning in the LN early (10 hr) versus late
(38 hr) after infection, we found marked differences for OT-I cells
and modest differences for OT-II cells (Figure 3C). This reflects
the predominant activation of OT-I at the SCS/IFA early after
infection (10 hr) versus the presence of antigen-bearing DCs in
the paracortex at later time points (38 hr). These paracortical
DCs were able to present antigen to and activate both OT-I
and OT-II T cells, as indicated by the OT-I and OT-II T cells ex-
pressing activation markers in co-clusters surrounding such
DCs (Figure 3D). Thus, later during infection, a common DC,
positioned in the peripheral paracortex, presents antigen able
to productively engage the TCR of both CD4+ and CD8+
T cells. Use of two experimental approaches to block DC migra-
tion (site removal, lymph vessel obliteration) revealed that migra-
tory DCs were not required for the formation of OT-I/OT-II cell
co-clusters during the late phase of infection (Figures S3A and
S3B). Additionally, Batf3 KO animals that lack migratory
CD103+ DCs but only a fraction of LN resident CD8a+ (XCR1+)
DCs (Edelson et al., 2010) showedmixed OT-I/OT-II cell co-clus-
ters, confirming that CD103+ migratory DCs were dispensable
for the formation of such clusters (Figure S3B). It is important
to note that the presence of clusters consisting of three different
cell types (OT-I/OT-II/DC) does not necessarily mean that those
ternary interactions occur or are necessary for delivery of help
under physiological conditions, as in these experiments an arti-
ficially high number of precursor T cells was used to facilitate
detection of the co-presenting DCs.
Non-infected Cross-presenting XCR1+ DCs Are the
Information-Transmission Platform for CD4+ and CD8+
T Cells
Given that XCR1+ DCs were dispensable for early CD4+ and
CD8+ T cell activation (Figure 1) but play a central role in immu-
nogenic CTL priming (Shortman and Heath, 2010), we hypothe-
sized that these DCs might be involved in the CD4+ and CD8+
T cell co-clustering we observed above. To investigate this hy-
pothesis, we first attempted to identify which DC subset pre-
sents antigen to OT-I cells at a late stage of infection. CD11b+
and CD8a+ DCswere sorted 30 hr after infection and co-cultured
with CFSE-labeled OT-I cells. In contrast to the results obtained
early (8 hr) after infection (Figure 1D), at this later time point,
exclusively CD8a+ (XCR1+) DCs induced OT-I cell proliferation
(Figures 4A, S4A, and S4B). To test whether this is due to the
known propensity of this DC subset to cross-present antigen,
we infected C57BL/6 and Kbm1mice with MVA-OVA-Kb, sorted
the CD8a+ DC subset 30 hr later, and co-incubated these DCs
with CFSE-labeled OT-I cells (Figure 4B). If direct antigen pre-
sentation was still occurring, directly infected Kbm1 DCs shouldovie S2.
at different time points after f.p. infection (MVA-OVA/MVA WT).
I cells (MVA-OVA-GFP), (E) transferred P14 and Smarta cells (MVA-GP-Venus);
. Histograms show distance of transferred cells from infected APC.
), (C and G, n = 4–8; pooled data) (D–F, n = 10). (B, C, and G) Red bars indicate
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still be able to drive OT-I cell proliferation due to virally driven Kb
expression (Figure 1B). However, this was not the case, support-
ing the notion that, later during infection, at least when using
replication-incompetent viruses, cross-presentation becomes
the dominant pathway for MHCI loading with viral antigens.
We then examined whether XCR1+ DCs also served as the
platform that communicates with both antigen-specific CD4+
and CD8+ T cells in vivo. We infected XCR1-DTR-Venus mice,
treated them with DTX or PBS, and transferred OT-I and OT-II
cells into these animals 30 hr post-infection and DTX treatment.
XCR1+ DCs were detected in the middle of mixed OT-I/OT-II cell
co-clusters in PBS-treated animals 8 hr after T cell transfer (Fig-
ure 4C). The XCR1+ DCswere not broadly distributed throughout
the LN as in the steady state (Figure S4C) but rather formed ag-
gregates that were intermixed with the co-clustered T cells (Fig-
ures 4C and S4D). DTX depletion of XCR1+ DCs led to a loss of
mixed OT-I/OT-II cell co-clusters, while leaving distinct OT-II and
separate, rare OT-I cell clusters (Figures 4C–4E). We next quan-
tified the requirement for XCR1+ DCs in the stimulation of OT-I
and OT-II cells at this late phase post-infection. 12 hr after
T cell transfer, we harvested the dLN and analyzed OT-I and
OT-II cells for CD69 expression using flow cytometry. In the
absence of XCR1+ DCs, the fraction of activated OT-I cells
dropped from 80% in WT to 15% in XCR1-DTR mice (Figure 4F).
The activation of OT-II cells was modestly reduced from 60% to
40% if XCR1+ DCs were absent. Together, these data indicate
that cross-presenting XCR1+DCs serve as a platform for interac-
tion (simultaneously or sequentially) with both antigen-specific
CD4+ and CD8+ T cells at late times after infection.
XCR1+ DCs Are Also Critical for Communication
between CD4+ and CD8+ T Cells during Productive VV
Infection
We next examined whether these findings applied to events
following infection with replication-competent VV that does not
require antigen cross-presentation for T cell priming due to
ongoing infection of DCs (Xu et al., 2010). First, we addressed
whether initial CD4+ and CD8+ T cell priming is also spatially
separated during VV infection. To this end, we transferred OT-I
and OT-II cells into WT animals and infected them with VV-
OVA. IVM 10 hr p.i. confirmed the near-absolute separation of
arrested OT-I and OT-II cells, with the former forming clusters
near the LN capsule and the latter in deeper areas of the LN (Fig-
ure 5A and Movie S4). Similar to MVA-OVA infection, VV-OVA
infection induced the accumulation of OT-I cells at the SCS,
where they interacted with infected DC (Figures 5B, S5A, and
S5B) (Hickman et al., 2011). In contrast, OT-II cells remained in
the paracortical areas of the LN and did not co-cluster with
OT-I (Figures 5B, S5C, and S5D).
Next, we addressed whether late co-clustering of CD8+ and
CD4+ T cells occurs after VV infection. Naive OT-I and OT-II cellsFigure 3. CD4+ and CD8+ T Cells Co-cluster Later during Infection
(A) Schematic of the experimental setup to reveal antigen-bearing cells later in th
(B) IF images of the dLN showing the localization of OT-I, OT-II, and control cells
(C) Histograms showing cellular localization 10 hr (see Figure 2) or 38 hr p.i. (see
(D) IF image of the dLN showing a mixed OT-I/OT-II cell cluster and activation st
Data are representative of 10 (B and D, n = 20) or three (C, n = 3) independent ex
1328 Cell 162, 1322–1337, September 10, 2015 ª2015 Elsevier Inc.were transferred into WT mice 30 hr post-infection, and the dLN
were examined by fluorescent microscopy 8 hr later. Central
sagittal sections showed that mixed T cell clusters consisted
of activated (CD69+) cells in the peripheral paracortex rather
than in the deep paracortical central region (Figures 5C and
S5E). Using VV-infected XCR1-DTR-Venus mice as recipients,
we found that mixed OT-I/OT-II cell co-clusters were organized
around XCR1+ DCs at this later time-point (Figure S5F). Deple-
tion of XCR1+ DCs led to a loss of mixed OT-I/OT-II cell clusters,
confirming that XCR1+ DCs are the predominant population
involved in co-presentation of MHCI and MHCII determinants
at this later stage, making them likely platforms for the delivery
of help (Figures 5D–5F). In the absence of XCR1+ DCs, OT-II
cell clusters were still present in the paracortex, typically in prox-
imity to the medullary area. OT-I cell clusters were also present
albeit in lower frequency and, importantly, were separated
from OT-II cells (Figures 5E and 5F). Persistent OT-I clusters in
the absence of XCR1+ DCs reflect ongoing VV replication and
continued infection of LN resident DCs. Such clusters were
largely absent after infection with the replication-deficient in
MVA (Figures 3C and 3D), most likely due to the absence of in-
fected DCs at this time point.
Localization of Endogenous Activated CD8+ T Cells
during VV Infection
We next turned to an assessment of whether endogenous T cells
are activated at similar anatomical sites as transferred TCR
transgenic cells and whether both CD4+ and CD8+ T cells simi-
larly seek out XCR1+ DCs later during infection. Labeled OT-I
cells were transferred to WT recipients and the mice infected
with VV-OVA. 8 hr later, we examined whether activated
(CD69hi) endogenous T cells were part of activatedOT-I cell clus-
ters. CD69hi non-transgenic cells were found in close proximity
to activated OT-I cells, arguing for an activation of endogenous
cells by the same DC (Figure 6A). To analyze the location of acti-
vated T cells later during infection when CD69 expression is
downregulated, we employed IFNg (YFP) reporter animals. As
expected, YFP-positive cells were not seen on fixed LN sections
from naive mice (Figure S6A). In contrast, at 38 hr p.i., we found
YFP-positive cells in the dLN that consisted of CD4+, CD8+, and
double-negative (CD3+) T cells, as well as NK cells (Figures 6B
and 6C). CD8+ T cells showed an increased cellular volume
(Figure 6D) and the highest YFP expression (Figure 6E) as
measured by forward scatter signal and the mean fluorescent in-
tensity (MFI).
Using immunofluorescent analysis of LN sections from IFNg
reporter animals 40 hr after infection (VV-OVA), we detected
YFP+ cells at the SCS and in the paracortex. To examine whether
the YFP+ cells represent recently activated T cells, we blocked
the entry of newly arriving naive T cells to the dLN using
CD62L antibodies 14 hr post-infection. Under this condition,e course of infection (MVA-OVA).
(polyclonal CD4 T cells).
experimental setup shown in A).
atus (CD69).
periments. Scale bars, (B) 200 mm/100 mm and (D) 10 mm. See also Figure S3.
AB
C
D E
F
Figure 4. Non-infected Cross-presenting XCR1+ DCs Are the Information-Transmission Platform for CD4+ and CD8+ T Cells
(A) Proliferation of CFSE-labeled OT-I cells after ex vivo coincubation with sorted splenic DC subsets (MVA-OVA; i.v.; 30 hr p.i.).
(B) Proliferation of CFSE-labeled OT-I cells after ex vivo coincubation with isolated splenic DC from WT or Kbm1 mice (MVA-OVA-Kb; i.v.; 30 hr p.i.).
(legend continued on next page)
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we found bright YFP+ CD8+ cells in the paracortex (Figure S6B).
Dim YFP+ cells positioned in the paracortex were CD4+, CD8+, or
double negative (Figure S6C). In contrast, YFP+ NK cells were
also dim but positioned at the SCS area rather than the paracor-
tex (Figures S6B and S6D). Even at a 100-fold higher dose of
VV-OVA (108), we did not observe cytokine-mediated activation
of endogenous CD44+ CD8+ T cells, arguing that the identified
enlarged, paracortical YFP+ CD8+ T cells reflect previously
activated antigen-specific T cells (Figure S6E). To determine
whether the location of such endogenous activated CD8+
T cells corresponds to areas of the dLN in which we expect
CD4+ T cell help to be delivered, we transferred OT-I cells as
described in Figure 3A. Endogenous YFP+ bright cells in the par-
acortex were CD69 negative or low and typically adjacent to
clustered, transferred OT-I cells (Figure 6F). Examination of the
distance between bright YFP+ cells in the paracortex and the
transferred activated OT-I cells revealed that the majority of
those cells were closer than 20 mm (Figure 6G). These several ob-
servations are consistent with the view that the sequential model
in which initial T cell priming occurs on distinct DC subsets in
different LN regions—and subsequently, information exchange
occurs on XCR1+ DCs as platform that co-presents antigen via
both MHCI andMHCII molecules—applies not just to TCR trans-
genic models, but to polyclonal anti-viral responses as well.
VV-Specific T Cells Activated in the Absence of XCR1+
DCs Are ‘‘Helpless’’
If the XCR1+ DC platform is dispensable for early CTL activation
but important for later differentiation and survival of the activated
CTL, XCR1+ DC depletion should negatively impact proliferation,
effector differentiation, and memory CTL function, equivalent to
the situation of CTL priming in the absence of CD4+ T cell help
(Wiesel and Oxenius, 2012). To test this prediction, we first
analyzed the CD8+ T cell immune response on day (d)8 after
VV infection in the presence or absence of CD4+ T cells. We
found a significant reduction in the total number of antigen-spe-
cific CD8+ T cells in the spleen on d8 after infection (Figure 7A). A
similar level of reduction in the immunodominant (B8R) CD8+
T cell response was also seen after depletion of XCR1+ DCs (Fig-
ure 7B). Combined CD4+ T cell and XCR1+ DC depletion showed
no additional reduction as compared to CD4+ T cell depletion
alone, arguing that help is delivered via XCR1+ DCs (Figure 7C).
To seewhether the observed reduction of the B8R-specific CD8+
T cell response upon XCR1+ DC depletion reflected the lack of
help delivered via this DC population and not an unrelated func-
tion independent of antigen presentation to CD4+ T cells, we
analyzed mixed BM (bone marrow) chimeric mice. MHCII KO x
XCR1-DTR BM chimeric mice (50/50) were generated and in-
fected with VV-OVA 8 weeks after reconstitution (Figures S7A
and S7B). In these animals, application of DTX results in a 50%
depletion of XCR1+ DCs with the remaining XCR1+ DCs lacking(C) Images of dLN using the experimental setup as in Figure 3A. XCR1-DTR-Ven
(D and E) T cell cluster abundance in the presence or absence of XCR1+ DC usin
(F) Analysis and representative plots of CD69 expression on OT-I/OT-II cells that
12 hr later in the dLN. Data are representative of three independent experiments
significant. (C) Scale bars, 50 mm.
See also Figure S4.
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a platform for delivery of help (Figure 7D). The depletion of XCR1+
MHCII+ DCs led to a significant reduction in the anti-viral B8R-
specific CD8+ T cell response on d8 post-priming (Figure 7E).
We further examined whether the absence of XCR1+ DCs im-
pacts CD8+ T cell differentiation to an effector or memory state
(Janssen et al., 2003; Shedlock and Shen, 2003; Sun and Bevan,
2003). We found a striking shift toward terminally differentiated
effector cells (CD127/KLRG1+) and a relative loss of memory
precursors (CD127+/KLRG1) if XCR1+ DCs were depleted (Fig-
ure 7F), along with a significant reduction in the capacity of the
activated CD8+ T cells to produce IL-2 (Figure 7G). A similar
loss in IL-2 producing cells was also observed when starting
the depletion after infection (Figures S7C–S7E). In contrast, the
capacity of antigen-specific CD8+ T cells to produce IFNg ap-
peared to be unaltered when comparing these conditions (Fig-
ure S7F). Next, we analyzed the memory response in mice that
were previously infected with VV-OVA in the presence or
absence of XCR1+ DCs. Interestingly, we detected only a small
but significant reduction in the total numbers of B8R multimer-
specific CD8+ T cell in the memory phase if XCR1+ DCs were ab-
sent during priming (Figure S7G). However, analysis of memory
subsets on d60 post-prime showed a significant increase in
KLRG1+ B8R multimer-specific memory T cells if XCR1+ DCs
were depleted during priming (Figures 7H and 7I). This memory
subset was characterized by prominent CD127 expression
typically seen in classical central memory T cells (CD127hi/
KLRG1). The antigen-specific CD8+ memory T cells had a full
capacity to produce IFNg if XCR1+ DCs were absent during
priming (Figure 7J). Yet, these memory CD8+ T cells had a pro-
found defect in IL-2 production (Figure 7K), which was charac-
terized by a reduction of polyfunctional T cells (IFNg+ TNFa+
IL-2+) (Figure 7K) and a reduced amount of IL-2 production on
a single-cell level as measured by the MFI (Figure S7H). Finally,
to test the capacity of thememory cells generated in the absence
or presence of XCR1+DCs to undergo optimal secondary expan-
sion, we rechallenged such mice with L. monocytogenes ex-
pressing the B8R peptide (Lm-B8R). 5 days after challenge, we
found that mice that lacked XCR1+ DCs during the priming
with VV-OVA failed to mount a robust recall response against
LM-B8R (Figure 7L), providing a physiological relevance of
XCR1+ DCs as a critical platform for delivery of cognate helper
signals from CD4+ T cells.
DISCUSSION
Here, we report the spatio-temporal dynamics of CD4+ and
CD8+ T cells early after viral infection and the role of distinct
DC subpopulations in both activation of and communication
between CD4+ and CD8+ T cells during this crucial phase of
the adaptive immune response. Our data reveal a complexus mice were treated with PBS or DTX.
g a (D) semi-automated or (E) fully automated analysis.
were transferred 28 hr post-infection (MVA-OVA/MVA WT; f.p.) and analyzed
(n = 8). (D–F) Red bars indicate mean values. ***p% 0.001, *p% 0.05; ns, non-
A B
C
D
E F
(legend on next page)
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choreography during the initiation of cell-mediated immunity, the
specific features of which help clarify what seem to be contradic-
tory observations in the literature.We find that (1) initial activation
of CD4+ and CD8+ T cells is spatially separated and involves
distinct DC; (2) CD8+ T cells are first activated by infected DC
and CD4+ T cells by non-infected DC; (3) later during infection
a third DC population (XCR1+ DCs) presents antigen to both
CD4+ and CD8+ T cells; and (4) these XCR1+ DCs are a platform
for communication between CD4+ and CD8+ T cells, shaping the
differentiation of the latter andmodulatingmemory programming
even in situations in which cross-presentation per se is not
required.
The finding that early CD4+ and CD8+ T cell activation post-
infection is separated and orchestrated at distinct anatomical
localizations was surprising. This feature may have been missed
in previous studies because of an exclusive focus on the dy-
namic behavior of CD8+ T cells (Hickman et al., 2008, 2011;
Kastenmu¨ller et al., 2013) or the use of peptide-pulsed DC
when co-analysis of both CD4+ and CD8+ behavior was studied
(Beuneu et al., 2006; Castellino et al., 2006). Several reports pre-
viously showed a propensity of distinct DC subsets to present
via either MHCI or MHCII molecules when using protein antigens
(den Haan et al., 2000; Dudziak et al., 2007; Schnorrer et al.,
2006). Factors that regulate such differential antigen-presenta-
tion among DC subsets have been described (Dudziak et al.,
2007; Vander Lugt et al., 2014), and numerous viral immune
evasion proteins that interfere with antigen-presentation have
been identified (Alcami and Koszinowski, 2000). However, the
profound spatial segregation of CD4+ versus CD8+ T cell activa-
tion early after infection requires additional investigation to more
fully understand the basis for this phenomenon and its relevance
to the acute and memory phases of immunity. Given the prefer-
ential localization of DC subsets within subregions of the LN
(Gerner et al., 2012; Kissenpfennig et al., 2005), these new find-
ings suggest a complex combination of intrinsic DC biology and
pathogen-associated effects on antigen presentation and local-
ization of DC subsets will greatly affect the nature of the ensuing
cell-mediated response.
It is unknown how many naive CD8+ T cells actually require
signals derived from CD4+ T cells to mount a robust and func-
tional memory CD8+ T cell response. In any given naive mouse
repertoire of a few hundred CD8+ T cells specific for a foreign
antigen, it might just be (the proliferative progeny of) a few initially
activated T cells that receive functional ‘‘help’’ fromCD4+ T cells.
This quantitative issue places some limits on the interpretation of
our results. Because we cannot directly visualize the specific
subset of ‘‘helped’’ CD8+ T cells as they receive the necessaryFigure 5. XCR1+ DCs Are the Information Transfer Platform for CD4+ a
(A) IF image and translated tracks from IVM of the popliteal LN 10–11 hr after VV
(B) IF images of a dLN showing the localization and cluster formation of transferred
and OT-II from capsule.
(C and D) IF images of the dLN of a XCR-DTR-Venus mice treated with PBS (C) o
experimental set-up shown in Figure 3A using VV-OVA. Histogram shows distan
(E and F) T cell cluster abundance in the presence or absence of XCR1+ DCs using
three independent experiments (n = 4). (E and F) Red bars indicatemean values. **
(B) 100 mm, (C) 200 mm, and (D) 200 mm/20 mm.
See also Figure S5 and Movie S4.
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that the relevant memory CD8+ T cell pool is formed by the
offspring of a few T cells that do not correspond to the bulk
behavior of the cells we quantify. Specifically, it is possible that
a minor, but biologically relevant population of naive CD8+
T cells encounters a cross-presenting (helped) XCR1+ DC first
rather than undergoing initial activation on a directly infected
non-licensed DC as in our proposed model.
Nonetheless, several lines of reasoning support the notion that
CD4+ T cell help is primarily delivered to activated rather than
naive CD8+ T cells. First, although CCR5 expression can occur
in a TCR-independent manner, optimal upregulation of this che-
mokine receptor occurs upon antigen activation, giving the
T cells the capacity to follow chemokine signals to the licensed
DCs (Castellino et al., 2006). Second, naive T cells interact for
many hours with DCs that present high-potency foreign anti-
gens. During this period (defined as phase II by Mempel et al.
[2004]), the DC-engaged CD8+ T cells would not be able to
search for the optimal (licensed) DCs. After these long-lasting in-
teractions, activated T cells enter a third phase that is character-
ized by short interactions with DCs (Mempel et al., 2004). To
date, the biological relevance of this third phase has remained
elusive. Our model assigns it a potential specific biological func-
tion, namely the search for licensed DCs. Third, besides CD8+
T cells, CD4+ T cells also require pre-activation in order to ex-
press themolecules that are required to deliver help, in particular
CD40 ligand (Bennett et al., 1998; Ridge et al., 1998; Schoen-
berger et al., 1998). Finally, our new model reveals a close simi-
larity between the cellular events that occur during CD4+ help for
B cells and for CD8+ T cells. B cells and CD8+ T cells are acti-
vated separately fromCD4+ T cell helpers at different anatomical
locations before they come together for signal exchange
(McHeyzer-Williams et al., 2006).
Besides the implication that pre-activated rather than naive
lymphocytes deliver/receive help, LN-resident XCR1+ DCs
have been identified as the critical platform on which such sig-
nals are transmitted. Interestingly, migratory DCs seemed
dispensable for initial CD8+ T cell activation or for provision of
help. Vaccinia virus particles directly disseminate to the dLN
after local intradermal infection of the skin (Lin et al., 2013), in
contrast to Herpes simplex virus that requires migratory DCs to
shuttle antigen to the dLN (Bedoui et al., 2009). With the latter
virus, migratory DCs are required to hand off antigen to LN-
resident DCs (Allan et al., 2006). This hand-off is in line with our
work showing the crucial requirement of LN-resident XCR1+
DCs rather thanmigratory DCs to act as a critical platform to pro-
vide help to CD8+ T cells.nd CD8+ T Cells during VV Infection
-OVA infection (f.p.). See also Movie S3.
OT-I andOT-II cells (VV-OVA; f.p.; 10 hr p.i.). Histogram shows distance of OT-I
r DTX (D) showing the localization of labeled OT-I and OT-II cells following the
ce of OT-I and OT-II from capsule.
a (E) semi-automated or (F) fully automated analysis. Data are representative of
*p% 0.001, **p% 0.01, and *p%0.05; ns, non-significant. Scale bars, (A) 50 mm,
AB
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Figure 6. Localization of Endogenous Activated CD8+ T Cells during VV Infection
(A) IF Images of a LN showing co-localization of transferred OT-I cells and endogenous (non-OT-I) CD69hi cells (VV-OVA; f.p.; 10 hr p.i.).
(B–E) Analysis of IFNg(YFP+) reporter animals (VV-OVA; 36 hr p.i.). (B) Graphs show the gating strategy, (C) the cellular distribution, (D) the size distribution, and (E)
the mean fluorescence intensity (MFI) of the YFP signal of IFNg+(YFP+) cells.
(F) IF images showing the localization of YFP-expressing cells 36 hr after infection of IFNg (YFP+) reporter animals (VV-OVA; f.p.). OT-I cells were transferred 8 hr
before analysis.
(G) Histogram shows the distance between IFNg+(YFP+) cells and activated (CD69hi) OT-I cells. Data are representative of at least two independent experiments.
(C), (E), and (G) show pooled data (C and E, n = 11) (G, n = 4). (C and E) Red bars indicate mean values. ***p% 0.001. Scale bar, (A) 10 mm and (F) 200 mm/10 mm.
See also Figure S6.
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Figure 7. VV-Specific T Cells Activated in the Absence of XCR1+ DC Are ‘‘Helpless’’
(A–C) Analysis of the total numbers of B8R multimer-specific splenic CD8+ T cells 8 days after VV-OVA infection (i.p.). Comparison of (A) isotype versus CD4
depleted mice, (B) WT versus XCR1-DTR mice treated with DTX, and (C) WT versus XCR1-DTR mice treated with DTX and anti-CD4 antibody.
(legend continued on next page)
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The XCR1+ DC subset has primarily received attention due to
its capacity to cross-present antigens (Shortman and Heath,
2010). Our experiments have uncovered an important additional
function by using a model that does not require cross-presenta-
tion for CD8+ T cell priming (Xu et al., 2010). In this situation, the
absence of XCR1+DCs had a small effect on the primary immune
response, compared to the absence of CD4+ T cell help. How-
ever, we found a profound role of XCR1+ DCs on the differentia-
tion of CD8+ T cells and the functionality of the resulting memory
T cells, which largely lacked the ability to produce the IL-2
needed for an optimal recall response (Feau et al., 2011). This
function of XCR1+ DCs is optimized by signals from CD4+ helper
T cells, which is consistent with the equivalent reduction of the
CD8+ T cell response after depletion of XCR1+ DCs or of CD4+
T cells (Figures 7A–7C).
The observations reported here provide a new level of under-
standing of the complex cell-cell interactions that underlie effec-
tive cell-mediated immune responses. Two distinct conventional
T cell subsets (CD4+ andCD8+abTcells) anda variety of different
DC subtypes (CD11b+, XCR1+, and possibly others) operate in a
staged, dynamic process to provide both early effectors and
memory cells that later support host defense upon re-infection.
In the context of previous findings on the contribution of chemo-
kine signaling to optimization of communication involving T cell
subsets and DCs (Castellino et al., 2006; Hickman et al., 2011;
Hugues et al., 2007) and evidence for phased changes in T cell
migratory dynamics after viral infection (Mempel et al., 2004),
we are now able to draw an increasing complete picture of how
this limb of the adaptive immune system operates to enable
rare cells to generate robust acute and memory responses. The
new evidence for distinct roles of DC subsets in primary activa-
tion of CD4+ versus CD8+ T cells and as a platform for their
communication also provides guidance for how to best direct
vaccine components to drive specific aspects of immunity.
EXPERIMENTAL PROCEDURES
Animals
Mice were purchased from Jackson or Janvier Labs or maintained at in-house
facilities. All mice were maintained in specific pathogen-free conditions at an
Association for Assessment and Accreditation of Laboratory Animal Care-
accredited animal facility. All procedures were approved by the NIAID Animal
Care and Use Committee (NIH) and the North Rhine-Westphalia State Environ-
ment Agency (LUA NRW), respectively. For details on mouse strains, see
Supplemental Information.
Viruses, Bacteria, and Infections
107-108 IU recombinant MVA, 106 107 PFU VV-OVA, 2x 107 PFU Ad-OVA-
GFP or 5x103 CFU LM-B8R were diluted in PBS and injected in the footpad
(foothock [Kamala, 2007]), i.v. or i.p.(D) Schematic of DC composition in BM chimeric animals (MHCII KO x XCR1-DT
(E) Antiviral CD8+ immune response is shown comparing DTX versus PBS-treate
(F and G) Analysis of B8R-specific immune responses d8 p.i. (VV-OVA i.p.), c
phenotype of B8R multimer-specific CD8+ T cells and (G) the number of IL-2-pro
(H–L) Analysis of the immune response 60 p.i. (VV-OVA i.p.), comparing WT versu
of B8R multimer-specific memory subsets. (J) Absolute numbers of IFNg-produc
IFNg+) after peptide (B8R) stimulation. (L) Recall response d5 after Lm-B8R challe
(B8R) stimulation. Data are representative of three or two (L) independent exper
*p% 0.05; ns, non-significant.
See also Figure S7.
CAdoptive T Cell Transfer
OT-I, OT-II, P14, Smarta, or polyclonal control CD4+ T cells were purified using
a MACS CD4- or CD8-negative selection kit (Miltenyi) combined with bio-
tinylated anti-CD44 (IM7, BD Biosciences). 2–43106 cells were transferred i.v.
In Vitro Proliferation Assay
OT-I cells were isolated and labeled with CFSE 5 mM (Invitrogen), followed by
an ex vivo 72 hr co-incubation with isolated splenic DCs or LN-derived DCs.
Isolation of DC and Cell Sorting
Spleens or LNs were harvested and digested with Collagenase D/DNase for
30 min followed by a DC enrichment step using MACS CD11c-positive
selection kit (Miltenyi) and sorting based on CD11c, MHCII, CD8, and
CD11b staining using a FACSAria (BD Biosciences) cell sorter. Cellular purity
was >95%.
Flow Cytometry
For analysis, LN and spleens were harvested and single-cell suspensions were
generated. For details on antibodies, see Supplemental Information.
Immunofluorescence Staining
PLP-fixed, frozen tissues were cut, stained, mounted, and acquired on a 710
confocal microscope (Carl Zeiss Microimaging). For details on antibodies, see
Supplemental Information.
Intravital Two-Photon Imaging
Mice were anesthetized, popliteal LNs were exposed, and intravital micro-
scopy was performed using a protocol modified from a previous report (Kas-
tenmu¨ller et al., 2013). Raw imaging data were processed and analyzed with
Imaris (Bitplane). For details, see Supplemental Information.
Analysis of Imaging Data
Images were systematically analyzed using a semi-automated (Imaris/
Bitplane) and a fully automated approach. For details, see Supplemental
Information.
Statistical Analysis
Student’s t test (two-tailed) and Mann-Whitney test were used for the statisti-
cal analysis of differences between two groups with normal and non-normal
distribution.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four movies and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2015.08.004.
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